<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="0.48.0">
<page number="1" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="0" size="10" family="Times" color="#231f20"/>
	<fontspec id="1" size="16" family="Times" color="#231f20"/>
	<fontspec id="2" size="14" family="Times" color="#231f20"/>
	<fontspec id="3" size="13" family="Times" color="#231f20"/>
	<fontspec id="4" size="14" family="Times" color="#231f20"/>
	<fontspec id="5" size="22" family="Times" color="#231f20"/>
	<fontspec id="6" size="25" family="Times" color="#231f20"/>
	<fontspec id="7" size="7" family="Times" color="#231f20"/>
	<fontspec id="8" size="14" family="Times" color="#231f20"/>
<text top="108" left="106" width="210" height="12" font="0">Archives of the Balkan Medical Union</text>
<text top="122" left="106" width="226" height="12" font="0">Copyright © 2019 Balkan Medical Union</text>
<text top="108" left="636" width="151" height="12" font="0">vol. 54, no. 2, pp. 351-356</text>
<text top="122" left="728" width="59" height="12" font="0">June 2019</text>
<text top="607" left="457" width="12" height="18" font="1">R</text>
<text top="611" left="469" width="43" height="13" font="0">ÉSUMÉ</text>
<text top="642" left="457" width="334" height="19" font="2"><b>Aspects cliniques bucco-dentaires chez les enfants </b></text>
<text top="661" left="457" width="95" height="19" font="2"><b>thalassémiques</b></text>
<text top="702" left="457" width="98" height="16" font="3">Introduction. </text>
<text top="698" left="559" width="233" height="19" font="4">Les thalassémies sont les maladies </text>
<text top="717" left="457" width="329" height="19" font="4">monogéniques les plus courantes. Elles sont divi-</text>
<text top="736" left="457" width="334" height="19" font="4">sées en deux grands groupes: les alpha-thalassémies </text>
<text top="754" left="457" width="334" height="19" font="4">(thalassémies mineures), qui ne présentent pas de </text>
<text top="773" left="457" width="330" height="19" font="4">symptomatologie particulière, et les bêta-thalassé-</text>
<text top="792" left="457" width="334" height="19" font="4">mies, qui sont une forme de maladie héréditaire de </text>
<text top="811" left="457" width="330" height="19" font="4">l’hémoglobine (hémoglobinopathie), une forme sé-</text>
<text top="829" left="457" width="334" height="19" font="4">vère d’anémie nécessitant un traitement pour la vie. </text>
<text top="848" left="457" width="329" height="19" font="4">Dans les cas de thalassémie majeure, analyse céto-</text>
<text top="867" left="457" width="333" height="19" font="4">gène, le défaut génétique se produit par délétions et </text>
<text top="886" left="457" width="329" height="19" font="4">mutations ponctuelles du gène qui contrôle la syn-</text>
<text top="904" left="457" width="334" height="19" font="4">thèse des chaînes alpha ou bêta de l’ARN messager </text>
<text top="923" left="457" width="335" height="19" font="4">au niveau du chromosome 11. C’est une maladie </text>
<text top="942" left="457" width="335" height="19" font="4">autosomique récessive. Les patients homozygotes </text>
<text top="961" left="457" width="335" height="19" font="4">porteurs de deux gènes béta-mutants présentent </text>
<text top="980" left="457" width="329" height="19" font="4">des formes graves de la maladie – les patients hé-</text>
<text top="998" left="457" width="335" height="19" font="4">térozygotes porteurs d’un seul allèle bêta-mutant </text>
<text top="1017" left="457" width="335" height="19" font="4">présentent des formes bénignes, mais il est très </text>
<text top="607" left="106" width="12" height="18" font="1">A</text>
<text top="611" left="118" width="55" height="13" font="0">BSTRACT</text>
<text top="646" left="106" width="94" height="16" font="3">Introduction. </text>
<text top="642" left="204" width="238" height="19" font="4">Thalassemias are the most common </text>
<text top="661" left="106" width="329" height="19" font="4">monogenic diseases. They are divided in two major cat-</text>
<text top="679" left="106" width="334" height="19" font="4">egories: alpha – thalassemias (minor thalassemia), that </text>
<text top="698" left="106" width="329" height="19" font="4">do not have a special symptomatology and beta-thalas-</text>
<text top="717" left="106" width="329" height="19" font="4">semias, which are a form of hereditary disease of he-</text>
<text top="736" left="106" width="334" height="19" font="4">moglobin (hemoglobinopathy), a severe form of anemia </text>
<text top="754" left="106" width="330" height="19" font="4">that requires treatment for life. In the case of major thal-</text>
<text top="773" left="106" width="334" height="19" font="4">assemias, ketogenic analysis, the genetic defect occurs </text>
<text top="792" left="106" width="334" height="19" font="4">through deletions and point mutations of the gene that </text>
<text top="811" left="106" width="330" height="19" font="4">controls the synthesis of alpha or beta chains in messen-</text>
<text top="829" left="106" width="330" height="19" font="4">ger RNA at chromosome 11 level. It is an autosomal re-</text>
<text top="848" left="106" width="330" height="19" font="4">cessive disease. Homozygous patients with two beta-mu-</text>
<text top="867" left="106" width="334" height="19" font="4">tant genes have severe forms of diseases; heterozygous </text>
<text top="886" left="106" width="330" height="19" font="4">patients with a single beta-mutant allele have mild dis-</text>
<text top="904" left="106" width="334" height="19" font="4">ease forms, but it is very important that they should be </text>
<text top="923" left="106" width="329" height="19" font="4">properly evaluated and diagnosed for genetic counseling.</text>
<text top="946" left="106" width="97" height="16" font="3">The objective </text>
<text top="942" left="207" width="234" height="19" font="4">was to describe dental abnormalities </text>
<text top="961" left="106" width="335" height="19" font="4">that  occur  in  case  of  thalassemias.  <b>Materials and </b></text>
<text top="979" left="106" width="333" height="19" font="2"><b>method</b>. Two clinical cases of two patients aged 2 years </text>
<text top="998" left="106" width="329" height="19" font="4">and 12 years, diagnosed with beta-thalassemia and al-</text>
<text top="1017" left="106" width="268" height="19" font="4">pha-thalassemia, respectively, are presented.</text>
<text top="200" left="454" width="333" height="24" font="5">CASE SERIES AND MINIREVIEW</text>
<text top="311" left="106" width="561" height="27" font="6">ORO-DENTAL CLINICAL ASPECTS IN CHILDREN </text>
<text top="341" left="106" width="245" height="27" font="6">WITH THALASSEMIA</text>
<text top="393" left="106" width="109" height="17" font="4">Andrei KOZMA</text>
<text top="392" left="215" width="6" height="10" font="7">1</text>
<text top="393" left="222" width="193" height="17" font="4">, Florentina VLADAREANU</text>
<text top="392" left="415" width="6" height="10" font="7">2</text>
<text top="393" left="421" width="171" height="17" font="4">, Doriana AGOP-FORNA</text>
<text top="392" left="592" width="6" height="10" font="7">3</text>
<text top="393" left="598" width="10" height="17" font="4">, </text>
<text top="411" left="106" width="222" height="17" font="4">Andreea D. IORDAN DUMITRU</text>
<text top="411" left="328" width="9" height="10" font="7">4 </text>
<text top="411" left="345" width="178" height="17" font="4">, Claudiu TOPOLICEANU</text>
<text top="411" left="523" width="6" height="10" font="7">5</text>
<text top="436" left="106" width="5" height="11" font="7">1</text>
<text top="435" left="111" width="631" height="19" font="4"> „Alessandrescu – Rusescu“ National Institute for Mother and Child Health, Bucharest, Romania</text>
<text top="455" left="106" width="5" height="11" font="7">2</text>
<text top="454" left="111" width="582" height="19" font="4"> „Prof. C.T. Nicolau“ National Institute of Transfusional Hematology, Bucharest, Romania</text>
<text top="473" left="106" width="5" height="11" font="7">3</text>
<text top="473" left="111" width="630" height="19" font="4"> Dental Medicine Faculty, “Grigore T. Popa“ University of Medicine and Pharmacy, Iasi, Romania</text>
<text top="492" left="106" width="5" height="11" font="7">4</text>
<text top="491" left="111" width="4" height="19" font="4"> </text>
<text top="493" left="115" width="462" height="17" font="3">„Titu Maiorescu“ University, Faculty of Dental Medicine, Bucharest, Romania</text>
<text top="511" left="106" width="5" height="11" font="7">5</text>
<text top="510" left="111" width="630" height="19" font="4"> Dental Medicine Faculty, “Grigore T. Popa“ University of Medicine and Pharmacy, Iasi, Romania</text>
<text top="529" left="518" width="269" height="19" font="8"><i>Received 10 Apr 2019, Accepted 23 May 2019</i></text>
<text top="552" left="549" width="237" height="12" font="0">https://doi.org/10.31688/ABMU.2019.54.2.21</text>
<text top="1079" left="143" width="167" height="13" font="0"> Address for correspondence:  </text>
<text top="1079" left="348" width="160" height="13" font="0"> Andreea D. IORDAN DUMITRU</text>
<text top="1096" left="348" width="412" height="13" font="0">„Titu Maiorescu“ University, Faculty of Dental Medicine, Bucharest, Romania</text>
<text top="1113" left="348" width="404" height="13" font="0">Address: Alba Iulia Square 3, bloc I 2, Ap. 1, sector 3, 031103 Bucharest, </text>
<text top="1131" left="348" width="47" height="13" font="0">Romania</text>
<text top="1148" left="348" width="304" height="13" font="0">Email: dona.iordan@yahoo.com; Phone +40 744310627</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="9" size="11" family="Times" color="#231f20"/>
<text top="91" left="106" width="415" height="14" font="9">Oro-dental clinical aspects in children with thalassemia – KOZMA et al</text>
<text top="1182" left="106" width="143" height="14" font="9">352  /  vol. 54, no. 2</text>
<text top="727" left="106" width="5" height="18" font="1">I</text>
<text top="731" left="112" width="85" height="13" font="0">NTRODUCTION</text>
<text top="762" left="136" width="300" height="19" font="4">Thalassemia is a disease characterized by the in-</text>
<text top="781" left="106" width="333" height="19" font="4">ability of erythroblasts to produce the -chain of the </text>
<text top="800" left="106" width="185" height="19" font="4">normal hemoglobin structure</text>
<text top="801" left="291" width="5" height="11" font="7">1</text>
<text top="800" left="295" width="4" height="19" font="4">.</text>
<text top="819" left="136" width="305" height="19" font="4">Thalassemia is considered the most common </text>
<text top="838" left="106" width="121" height="19" font="4">monogenic disease</text>
<text top="839" left="227" width="5" height="11" font="7">2</text>
<text top="838" left="232" width="208" height="19" font="4">. Beta-thalassemia occurs when </text>
<text top="857" left="106" width="334" height="19" font="4">a mutated gene is inherited from both parents, and </text>
<text top="876" left="106" width="330" height="19" font="4">Alpha-thalassemia is established when the child in-</text>
<text top="895" left="106" width="191" height="19" font="4">herits a single mutation gene</text>
<text top="896" left="298" width="5" height="11" font="7">3</text>
<text top="895" left="303" width="138" height="19" font="4">. Beta-thalassemia is </text>
<text top="914" left="106" width="335" height="19" font="4">commonly found in the Mediterranean Sea basin </text>
<text top="933" left="106" width="185" height="19" font="4">(Greek “thalassa“ means sea)</text>
<text top="934" left="292" width="5" height="11" font="7">4</text>
<text top="933" left="296" width="140" height="19" font="4">. It is an endemic dis-</text>
<text top="952" left="106" width="329" height="19" font="4">ease in areas in the Middle East, India, or in tropi-</text>
<text top="971" left="106" width="334" height="19" font="4">cal areas, but it can also be found in non-endemic </text>
<text top="990" left="106" width="320" height="19" font="4">areas (such as northern Europe) due to migration</text>
<text top="991" left="427" width="5" height="11" font="7">5</text>
<text top="990" left="432" width="8" height="19" font="4">. </text>
<text top="1009" left="106" width="336" height="19" font="4">The explanation of increased frequency in the </text>
<text top="1028" left="106" width="329" height="19" font="4">Mediterranean or tropical area is the defense mecha-</text>
<text top="1047" left="106" width="330" height="19" font="4">nism of the human body against malaria, with het-</text>
<text top="1066" left="106" width="189" height="19" font="4">erozygotic being advantageous</text>
<text top="1067" left="295" width="5" height="11" font="7">6</text>
<text top="1066" left="300" width="4" height="19" font="4">.</text>
<text top="1085" left="136" width="304" height="19" font="4">Beta-thalassemias can be minor, moderate and </text>
<text top="1104" left="106" width="329" height="19" font="4">severe. In the case of major thalassemia, genetic de-</text>
<text top="1123" left="106" width="333" height="19" font="4">fects occur through deletions and point mutations of </text>
<text top="1142" left="106" width="334" height="19" font="4">the gene that controls the synthesis of alpha or beta </text>
<text top="727" left="457" width="333" height="19" font="4">chains in messenger RNA at the level of chromosome </text>
<text top="746" left="457" width="334" height="19" font="4">11. It is an autosomal recessive disease. Homozygous </text>
<text top="765" left="457" width="334" height="19" font="4">patients with 2 betamutant genes have serious forms </text>
<text top="784" left="457" width="329" height="19" font="4">of disease – heterozygous patients with a single be-</text>
<text top="803" left="457" width="333" height="19" font="4">ta-mutant allele have mild disease forms, but it is very </text>
<text top="821" left="457" width="329" height="19" font="4">important that they are properly evaluated and diag-</text>
<text top="840" left="457" width="178" height="19" font="4">nosed for genetic counseling</text>
<text top="841" left="635" width="5" height="11" font="7">7</text>
<text top="840" left="639" width="4" height="19" font="4">.</text>
<text top="859" left="487" width="303" height="19" font="4">Clinical picture – children with Cooley’s anemia </text>
<text top="878" left="457" width="329" height="19" font="4">exhibit a height and weight hypotrophy. The charac-</text>
<text top="897" left="457" width="333" height="19" font="4">teristics are: facial dysmorphism with macrocranium, </text>
<text top="916" left="457" width="334" height="19" font="4">proeminent malar bones, hypertelorism, low root of </text>
<text top="934" left="457" width="334" height="19" font="4">the nose insertion, spleno-hepatomegaly, increased </text>
<text top="953" left="457" width="333" height="19" font="4">abdomen, heart failure, bone fragility. At the lower </text>
<text top="972" left="457" width="333" height="19" font="4">level of the face we encounter a voluminous jaw with </text>
<text top="991" left="457" width="330" height="19" font="4">prognatism, protrusion of the upper lip, hypertro-</text>
<text top="1010" left="457" width="302" height="19" font="4">phied gums, small teeth with implantation vices</text>
<text top="1011" left="759" width="5" height="11" font="7">8</text>
<text top="1010" left="764" width="4" height="19" font="4">.</text>
<text top="1029" left="487" width="300" height="19" font="4">The diagnosis is established by a rigorous anam-</text>
<text top="1048" left="457" width="334" height="19" font="4">nesis with heredo-collateral history. Paraclinic tests </text>
<text top="1066" left="457" width="333" height="19" font="4">may detect chronic hemolytic anemia, reticulocytosis, </text>
<text top="1085" left="457" width="329" height="19" font="4">increased hemoglobin percentage, increased iron up-</text>
<text top="1104" left="457" width="130" height="19" font="4">take in the intestine.</text>
<text top="1105" left="588" width="5" height="11" font="7">8</text>
<text top="1104" left="592" width="4" height="19" font="4">.</text>
<text top="1123" left="487" width="304" height="19" font="4">The indicated treatment is customized for each </text>
<text top="1142" left="457" width="333" height="19" font="4">patient, taking into account: medical history, age, </text>
<text top="126" left="457" width="329" height="19" font="4">important qu’ils soient correctement évalués et dia-</text>
<text top="145" left="457" width="244" height="19" font="4">gnostiqués pour un conseil génétique.</text>
<text top="168" left="457" width="68" height="16" font="3">L’objectif </text>
<text top="164" left="528" width="263" height="19" font="4">est de décrire les anomalies dentaires qui </text>
<text top="182" left="457" width="223" height="19" font="4">surviennent en cas de thalassémie.</text>
<text top="205" left="457" width="152" height="16" font="3">Matériel et méthode. </text>
<text top="201" left="613" width="177" height="19" font="4">Deux cas cliniques de deux </text>
<text top="220" left="457" width="330" height="19" font="4">patients âgés respectivement de 2 et 12 ans, diagnos-</text>
<text top="239" left="457" width="329" height="19" font="4">tiqués avec une bêta-thalassémie et une alpha-thalas-</text>
<text top="257" left="457" width="139" height="19" font="4">sémie, sont présentés.</text>
<text top="280" left="457" width="81" height="16" font="3">Résultats. </text>
<text top="276" left="541" width="245" height="19" font="4">Les perturbations survenues ont en-</text>
<text top="295" left="457" width="335" height="19" font="4">traîné un dysfonctionnement physionomique, un </text>
<text top="314" left="457" width="334" height="19" font="4">dysfonctionnement masticatoire, pour lesquels les </text>
<text top="332" left="457" width="329" height="19" font="4">patients ont sollicité des soins dentaires. Le pro-</text>
<text top="351" left="457" width="335" height="19" font="4">blème principal est l’optimisation de la fonction </text>
<text top="370" left="457" width="329" height="19" font="4">masticatoire qui peut être résolue à cet âge et résou-</text>
<text top="389" left="457" width="329" height="19" font="4">dra le trouble de la phonation, suivie de la supervi-</text>
<text top="407" left="457" width="334" height="19" font="4">sion du processus de croissance et de l’intervention </text>
<text top="426" left="457" width="334" height="19" font="4">d’autres solutions de traitement après la fermeture </text>
<text top="445" left="457" width="334" height="19" font="4">du processus. <b>Conclusions</b>. Le tableau clinique des </text>
<text top="464" left="457" width="329" height="19" font="4">patients de l’étude reproduit les données de la litté-</text>
<text top="482" left="457" width="329" height="19" font="4">rature de spécialité: anomalies structurelles provo-</text>
<text top="501" left="457" width="334" height="19" font="4">quant des caries dentaires évolutives graves. Dans </text>
<text top="520" left="457" width="334" height="19" font="4">ce cas, un suivi régulier au cabinet dentaire est très </text>
<text top="539" left="457" width="334" height="19" font="4">important mais bénéfique en même temps. Dans un </text>
<text top="557" left="457" width="333" height="19" font="4">état nutritionnel et nutritionnel approprié – dans le </text>
<text top="576" left="457" width="333" height="19" font="4">contexte de l’anémie chronique sévère, nous devons </text>
<text top="595" left="457" width="334" height="19" font="4">éviter l’apparition de crises hémolytiques causées </text>
<text top="614" left="457" width="251" height="19" font="4">par des épidémies d’infection dentaire.</text>
<text top="655" left="457" width="80" height="16" font="3">Mots-clés: </text>
<text top="651" left="541" width="246" height="19" font="4">thalassémie, anomalies dentaires, dys-</text>
<text top="670" left="457" width="190" height="19" font="4">fonctionnement masticatoire.</text>
<text top="130" left="106" width="59" height="16" font="3">Results. </text>
<text top="126" left="168" width="271" height="19" font="4">The disruptions that occurred, have resulted </text>
<text top="145" left="106" width="333" height="19" font="4">in physiognomic dysfunction, masticatory dysfunction, </text>
<text top="164" left="106" width="335" height="19" font="4">for which patients have requested dental care. The </text>
<text top="182" left="106" width="334" height="19" font="4">main problem is the optimization of the masticatory </text>
<text top="201" left="106" width="329" height="19" font="4">function, that can be solved at the age of the investigat-</text>
<text top="220" left="106" width="333" height="19" font="4">ed patients, and will also solve the phonation disorder, </text>
<text top="239" left="106" width="333" height="19" font="4">followed by the supervision of the growth process and </text>
<text top="257" left="106" width="334" height="19" font="4">the intervention with other treatment solutions after </text>
<text top="276" left="106" width="159" height="19" font="4">the closure of the process.</text>
<text top="299" left="106" width="92" height="16" font="3">Conclusions. </text>
<text top="295" left="201" width="239" height="19" font="4">The clinical picture of the patients in </text>
<text top="314" left="106" width="329" height="19" font="4">the study reproduces the data from the specialized lit-</text>
<text top="332" left="106" width="329" height="19" font="4">erature: structural abnormalities causing severe evolv-</text>
<text top="351" left="106" width="334" height="19" font="4">ing dental cavities. Regular follow-ups at the dental </text>
<text top="370" left="106" width="334" height="19" font="4">office in this case are very important but beneficial </text>
<text top="389" left="106" width="334" height="19" font="4">at the same time. In a proper feeding and nutritional </text>
<text top="407" left="106" width="329" height="19" font="4">state – against the background of severe chronic ane-</text>
<text top="426" left="106" width="334" height="19" font="4">mia, we need to avoid the onset of hemolytic crises </text>
<text top="445" left="106" width="244" height="19" font="4">caused by outbreaks of dental infection.</text>
<text top="486" left="106" width="74" height="16" font="3">Keywords: </text>
<text top="482" left="183" width="252" height="19" font="4">thalassemia, dental abnormalities, masti-</text>
<text top="501" left="106" width="117" height="19" font="4">catory dysfunction.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="10" size="11" family="Times" color="#231f20"/>
<image top="705" left="457" width="330" height="418" src="/export/freefileconvert/13160_26d5613051bc52460863b7f656d61c1ab70c93db28550ed3e9f3f2c9825989d8-3_1.png"/>
<text top="91" left="552" width="235" height="14" font="9">Archives of the Balkan Medical Union</text>
<text top="1182" left="660" width="42" height="14" font="9">June </text>
<text top="1182" left="693" width="94" height="14" font="9">2019 / 353</text>
<text top="126" left="106" width="334" height="19" font="4">health state and the recommendation of a healthy </text>
<text top="146" left="106" width="335" height="19" font="4">lifestyle with hygiene (including dental hygiene) – </text>
<text top="166" left="106" width="334" height="19" font="4">rules strictly observed. The definitive treatment of </text>
<text top="186" left="106" width="333" height="19" font="4">the disease is allogenic bone marrow transplantation </text>
<text top="206" left="106" width="97" height="19" font="4">from the donor</text>
<text top="207" left="203" width="5" height="11" font="7">9</text>
<text top="206" left="208" width="4" height="19" font="4">.</text>
<text top="247" left="106" width="10" height="18" font="1">T</text>
<text top="251" left="115" width="16" height="13" font="0">HE</text>
<text top="247" left="131" width="5" height="18" font="1"> </text>
<text top="251" left="137" width="64" height="13" font="0">OBJECTIVE</text>
<text top="247" left="201" width="5" height="18" font="1"> </text>
<text top="245" left="207" width="233" height="19" font="4">was to describe dental abnormalities </text>
<text top="265" left="106" width="214" height="19" font="4">that occur in case of thalassemias.</text>
<text top="306" left="106" width="16" height="18" font="1">M</text>
<text top="310" left="122" width="49" height="13" font="0">ATERIAL</text>
<text top="306" left="171" width="5" height="18" font="1"> </text>
<text top="310" left="177" width="25" height="13" font="0">AND</text>
<text top="306" left="202" width="5" height="18" font="1"> </text>
<text top="310" left="208" width="51" height="13" font="0">METHOD</text>
<text top="342" left="136" width="305" height="19" font="4">The cases that the authors dealt with are part </text>
<text top="362" left="106" width="334" height="19" font="4">of a retrospective epidemiological study of patients </text>
<text top="382" left="106" width="334" height="19" font="4">hospitalized for genetic diseases from whom it was </text>
<text top="402" left="106" width="329" height="19" font="4">chosen a group of patients with genetic diseases asso-</text>
<text top="422" left="106" width="198" height="19" font="4">ciated with oral manifestations.</text>
<text top="442" left="136" width="300" height="19" font="4">The research was carried out using the admis-</text>
<text top="462" left="106" width="333" height="19" font="4">sions register and the medical records of the patients </text>
<text top="482" left="106" width="334" height="19" font="4">admitted (observation sheets, paraclinical analyses </text>
<text top="502" left="106" width="334" height="19" font="4">attached to the observation sheet). For the study of </text>
<text top="522" left="106" width="334" height="19" font="4">the medical papers, we have requested and received </text>
<text top="542" left="106" width="334" height="19" font="4">the approval of the hospital management and of the </text>
<text top="562" left="106" width="284" height="19" font="4">committee of ethics in research-development.</text>
<text top="582" left="136" width="304" height="19" font="4">Two  groups  of  patients  admitted  between </text>
<text top="602" left="106" width="334" height="19" font="4">1990-1996 (group A) and 2010-2016 (group B) were </text>
<text top="622" left="106" width="329" height="19" font="4">included in the study. For each group, the initial eli-</text>
<text top="642" left="106" width="129" height="19" font="4">gibility criteria were:</text>
<text top="660" left="106" width="333" height="20" font="4">  all patients with genetic diseases admitted to the </text>
<text top="682" left="121" width="271" height="19" font="4">hospital unit during the respective periods;</text>
<text top="700" left="106" width="329" height="20" font="4"> diagnosis of genetic disease established and con-</text>
<text top="722" left="121" width="191" height="19" font="4">firmed by cytogenetic analysis.</text>
<text top="742" left="136" width="300" height="19" font="4">From all the patients admitted with genetic dis-</text>
<text top="762" left="106" width="334" height="19" font="4">eases, only patients with genetic diseases who also </text>
<text top="782" left="106" width="334" height="19" font="4">had oral manifestations were subsequently retained </text>
<text top="802" left="106" width="330" height="19" font="4">for the study. Regarding the patients with genetic dis-</text>
<text top="822" left="106" width="329" height="19" font="4">eases associated with oral manifestations, the param-</text>
<text top="842" left="106" width="269" height="19" font="4">eters used for the study were the following:</text>
<text top="860" left="106" width="330" height="20" font="4">  the age at which the genetic disease with oral man-</text>
<text top="882" left="121" width="162" height="19" font="4">ifestations was diagnosed;</text>
<text top="900" left="106" width="94" height="20" font="4"> patient’s sex;</text>
<text top="920" left="106" width="142" height="20" font="4"> origin environment;</text>
<text top="940" left="106" width="125" height="20" font="4">  rank of the child;</text>
<text top="960" left="106" width="173" height="20" font="4">  type of oral lesion found.</text>
<text top="982" left="136" width="300" height="19" font="4">For the study, a clinical examination of 52 pa-</text>
<text top="1002" left="106" width="334" height="19" font="4">tients diagnosed with a rascal genetic disease in the </text>
<text top="1022" left="106" width="334" height="19" font="4">oral cavity was performed. The present study only </text>
<text top="1042" left="106" width="335" height="19" font="4">dealt with bucco-dental aspects of children with </text>
<text top="1062" left="106" width="77" height="19" font="4">thalassemia.</text>
<text top="1082" left="136" width="305" height="19" font="4">For the photographs of the patients, we asked </text>
<text top="1102" left="106" width="333" height="19" font="4">for the confirmed consent of tutors, after their rights </text>
<text top="1122" left="106" width="333" height="19" font="4">were presented. In the following we present two cases </text>
<text top="1142" left="106" width="113" height="19" font="4">from our practice.</text>
<text top="126" left="457" width="12" height="18" font="1">C</text>
<text top="130" left="469" width="31" height="13" font="0">ASES</text>
<text top="126" left="500" width="5" height="18" font="1"> </text>
<text top="130" left="506" width="89" height="13" font="0">PRESENTATION</text>
<text top="166" left="457" width="295" height="15" font="3">Case 1 – severe beta-thalassemia (Cooley)</text>
<text top="181" left="487" width="304" height="19" font="4">General data: male patient, aged 12 years, weight </text>
<text top="201" left="457" width="168" height="19" font="4">27 kg, urban environment.</text>
<text top="220" left="487" width="191" height="19" font="4">Collateral hereditary history:</text>
<text top="238" left="457" width="333" height="20" font="4"> Mother – 40 years of age, primi-gesta, primi-para, </text>
<text top="259" left="472" width="290" height="19" font="4">diagnosed at 30 years with minor thalassemia.</text>
<text top="277" left="457" width="329" height="20" font="4"> Father – 40 year-old, diagnosed with minor thalas-</text>
<text top="298" left="472" width="108" height="19" font="4">semia at 31 years.</text>
<text top="315" left="457" width="330" height="20" font="4"> Observed pregnancy with late pregnancy patholog-</text>
<text top="337" left="472" width="81" height="19" font="4">ical disorder.</text>
<text top="356" left="487" width="199" height="19" font="4">Personal physiological history:</text>
<text top="374" left="457" width="330" height="20" font="4"> Child born on term with 2400 g, with good post-</text>
<text top="395" left="472" width="115" height="19" font="4">natal development</text>
<text top="416" left="487" width="148" height="17" font="3">Personal medical history</text>
<text top="414" left="635" width="4" height="19" font="4">:</text>
<text top="432" left="457" width="334" height="20" font="4"> Mother says he was pale „from birth“. At the age </text>
<text top="453" left="472" width="319" height="19" font="4">of one year and a half, he was hospitalized in a </text>
<text top="473" left="472" width="318" height="19" font="4">pediatric hospital in Bucharest, Romania, for an </text>
<text top="492" left="472" width="252" height="19" font="4">intercurrent upper respiratory infection.</text>
<text top="511" left="487" width="305" height="19" font="4">Clinical examination – at this admission the </text>
<text top="531" left="457" width="335" height="19" font="4">following are noted: pale skin and pale mucous </text>
<text top="550" left="457" width="335" height="19" font="4">membranes, splenomegaly. The haemogram shows </text>
<text top="570" left="457" width="329" height="19" font="4">hypochromic anemia, and the smear reveals an in-</text>
<text top="589" left="457" width="334" height="19" font="4">creased number of reticulocytes and cells as a sign </text>
<text top="608" left="457" width="335" height="19" font="4">of targeting suggestive of thalassemia. Pathological </text>
<text top="628" left="457" width="333" height="19" font="4">hemoglobin electrophoresis was performed showing a </text>
<text top="647" left="457" width="333" height="19" font="4">high percentage of fetal hemoglobin and hemoglobin </text>
<text top="1128" left="527" width="194" height="15" font="10"><b>Figure 1. </b>Facial and dental aspect </text>
<text top="1145" left="524" width="196" height="15" font="9">of 12 years old thalassemic patient.</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="1262" width="892">
<text top="91" left="106" width="415" height="14" font="9">Oro-dental clinical aspects in children with thalassemia – KOZMA et al</text>
<text top="1182" left="106" width="143" height="14" font="9">354  /  vol. 54, no. 2</text>
<text top="126" left="106" width="334" height="19" font="4">A2. From the age of one year, the child returns to </text>
<text top="145" left="106" width="333" height="19" font="4">the pediatric-hematology department for substitution </text>
<text top="165" left="106" width="310" height="19" font="4">treatment – isogroup / isoRh blood transfusions.</text>
<text top="184" left="136" width="306" height="19" font="4">General clinical examination (on admission </text>
<text top="203" left="106" width="333" height="19" font="4">from the time of study): marked pale skin and pale </text>
<text top="222" left="106" width="330" height="19" font="4">mucous membranes, facial dismophysis with mongol-</text>
<text top="241" left="106" width="334" height="19" font="4">oid facies, prominent malar bones, “turiform“ skull, </text>
<text top="260" left="106" width="330" height="19" font="4">hypertelorism, epicanthus and significant spleno-</text>
<text top="280" left="106" width="46" height="19" font="4">megaly.</text>
<text top="299" left="136" width="300" height="19" font="4">Exobuccal examination: a facies with pale tegu-</text>
<text top="318" left="106" width="141" height="19" font="4">ment is shown (Fig. 1).</text>
<text top="337" left="136" width="304" height="19" font="4">The middle floor highlights a small sized nasal </text>
<text top="356" left="106" width="330" height="19" font="4">pyramid. At the lower floor level, the mandible is ret-</text>
<text top="375" left="106" width="333" height="19" font="4">rograde. The functional examination reveals occlusal, </text>
<text top="395" left="106" width="213" height="19" font="4">structural and aesthetic disorders.</text>
<text top="414" left="136" width="273" height="19" font="4">The patient has the following dental status:</text>
<text top="460" left="120" width="10" height="15" font="9">rr</text>
<text top="460" left="245" width="68" height="15" font="9">mvpc mpvc</text>
<text top="460" left="420" width="10" height="15" font="9">rr</text>
<text top="484" left="119" width="13" height="15" font="9">16</text>
<text top="484" left="150" width="85" height="15" font="9">15 14 13 12</text>
<text top="484" left="253" width="13" height="15" font="9">11</text>
<text top="484" left="293" width="13" height="15" font="9">21</text>
<text top="484" left="323" width="108" height="15" font="9">22 23 24 25 26</text>
<text top="508" left="119" width="14" height="15" font="9">46</text>
<text top="508" left="150" width="85" height="15" font="9">85 44 43 42</text>
<text top="508" left="253" width="13" height="15" font="9">41</text>
<text top="508" left="293" width="13" height="15" font="9">31</text>
<text top="508" left="323" width="108" height="15" font="9">32 33 34 35 36</text>
<text top="531" left="111" width="53" height="15" font="9">modc Rr</text>
<text top="567" left="136" width="304" height="19" font="4">Carious activity is significant in teeth of upper </text>
<text top="586" left="106" width="330" height="19" font="4">jaw. 11, 21 teeth with significant coronary distruc-</text>
<text top="605" left="106" width="333" height="19" font="4">tion (mezio-vestibulary-palatinal caries mvpc). 11 also </text>
<text top="624" left="106" width="334" height="19" font="4">has a cavity in the form of a groove parallel to the </text>
<text top="644" left="106" width="329" height="19" font="4">incision edge. The enamel aspect shows areas of hy-</text>
<text top="663" left="106" width="333" height="19" font="4">pomineralization. Spots of enamel hypoplasia are also </text>
<text top="682" left="106" width="227" height="19" font="4">present at the level of 22, 23, 12, 13.</text>
<text top="701" left="136" width="300" height="19" font="4">In the maxillary dental arch, which is promi-</text>
<text top="720" left="106" width="334" height="19" font="4">nent, there are also severe carious processes at the </text>
<text top="739" left="106" width="272" height="19" font="4">level of 16 and 26 – residual tooth root (rr).</text>
<text top="759" left="136" width="303" height="19" font="4">At mandibular level, the teeth (31, 32, 33, 41, 42, </text>
<text top="778" left="106" width="334" height="19" font="4">43) have a yellowish coloration. The lower right first </text>
<text top="797" left="106" width="333" height="19" font="4">molar has a medio-occlusal-distal caries (modc) and </text>
<text top="816" left="106" width="334" height="19" font="4">the second deciduous molar is still present on the </text>
<text top="835" left="106" width="212" height="19" font="4">dental arch as radicular rest (rr).</text>
<text top="855" left="136" width="304" height="19" font="4">The crowns of 41 and 31 show a possible white </text>
<text top="874" left="106" width="110" height="19" font="4">demineralization.</text>
<text top="893" left="136" width="225" height="19" font="4">The palatine vault is tall and ogival.</text>
<text top="912" left="136" width="304" height="19" font="4">The gingival mucosa is inflamed and bleeding </text>
<text top="931" left="106" width="114" height="19" font="4">at the mere touch.</text>
<text top="950" left="136" width="189" height="19" font="4">Oral hygiene is unsatisfactory.</text>
<text top="1012" left="106" width="48" height="15" font="3">Case 2</text>
<text top="1027" left="136" width="304" height="19" font="4">Minor beta-thalassemia – hemoglobinopathy, a </text>
<text top="1046" left="106" width="276" height="19" font="4">monogenic disease – the heterozygous form.</text>
<text top="1065" left="136" width="303" height="19" font="4">General data: male, aged 5 years and one month, </text>
<text top="1084" left="106" width="208" height="19" font="4">weight 10 kg, urban environment</text>
<text top="1103" left="136" width="191" height="19" font="4">Collateral hereditary history:</text>
<text top="1121" left="106" width="329" height="20" font="4"> 22-year-old mother, apparently healthy, primipa-</text>
<text top="1142" left="121" width="290" height="19" font="4">rous (under investigation at the time of study).</text>
<text top="124" left="457" width="329" height="20" font="4">  23-year-old father, apparently healthy (under inves-</text>
<text top="145" left="472" width="182" height="19" font="4">tigation at the time of study).</text>
<text top="162" left="457" width="336" height="20" font="4"> Monitored normal pregnancy, anemic mother </text>
<text top="183" left="472" width="114" height="19" font="4">during pregnancy.</text>
<text top="201" left="487" width="199" height="19" font="4">Personal physiological history:</text>
<text top="218" left="457" width="329" height="20" font="4"> First delivered in term, 3100 g, good postnatal de-</text>
<text top="239" left="472" width="69" height="19" font="4">velopment.</text>
<text top="259" left="487" width="148" height="17" font="3">Personal medical history</text>
<text top="258" left="635" width="4" height="19" font="4">:</text>
<text top="275" left="457" width="333" height="20" font="4"> Admitted to a pediatric hospital in Bucharest for a </text>
<text top="296" left="472" width="314" height="19" font="4">digestive disorder, is found with hypochromic ane-</text>
<text top="314" left="472" width="181" height="19" font="4">mia (change in blood smear).</text>
<text top="331" left="457" width="334" height="20" font="4"> Pathological hemoglobin electrophoresis, showing </text>
<text top="352" left="472" width="234" height="19" font="4">12% A2 hemoglobin, was performed.</text>
<text top="369" left="457" width="330" height="20" font="4"> Hematologic diagnosis shows minor beta-thalassem-</text>
<text top="390" left="472" width="15" height="19" font="4">ia.</text>
<text top="409" left="487" width="304" height="19" font="4">Clinical general examination – visible pale skin </text>
<text top="427" left="457" width="333" height="19" font="4">and pale mucous membranes, discreet perioral nasal </text>
<text top="446" left="457" width="334" height="19" font="4">cyanosis. The feeling of the lower pole of the spleen </text>
<text top="465" left="457" width="330" height="19" font="4">at 2 cm under the rebord was confirmed by ultra-</text>
<text top="484" left="457" width="126" height="19" font="4">sound investigation.</text>
<text top="503" left="487" width="305" height="19" font="4">The facial examination reveals pale skin with </text>
<text top="521" left="457" width="334" height="19" font="4">mild peribuccal cyanosis. At the endobuccal level, </text>
<text top="540" left="457" width="325" height="19" font="4">implantation and shape abnormalities are observed.</text>
<text top="559" left="487" width="304" height="19" font="4">The patient has temporary (decidual) dentition </text>
<text top="578" left="457" width="223" height="19" font="4">and has the following dental status:</text>
<text top="623" left="698" width="12" height="15" font="9">oc</text>
<text top="646" left="509" width="225" height="15" font="9">55 54 53 52 51 61 62 63 64 65</text>
<text top="670" left="509" width="225" height="15" font="9">85 84 83 82 81 71 72 73 74 65</text>
<text top="693" left="533" width="12" height="15" font="9">oc</text>
<text top="727" left="487" width="303" height="19" font="4">The teeth present microdontia (size abnormality) </text>
<text top="746" left="457" width="330" height="19" font="4">and position defects, with increased space in the up-</text>
<text top="765" left="457" width="334" height="19" font="4">per incisive area; between the upper central incisors </text>
<text top="784" left="457" width="334" height="19" font="4">we noticed a 2mm space – diastema (Fig. 2-a). In the </text>
<text top="803" left="457" width="334" height="19" font="4">area of the central and lateral lower incisors can be </text>
<text top="821" left="457" width="333" height="19" font="4">noticed bilaterally – a space of 2.5 mm in right dental </text>
<text top="840" left="457" width="334" height="19" font="4">hemiarcade and 1.5 mm respectively in the left side </text>
<text top="859" left="457" width="58" height="19" font="4">(Fig. 2-b).</text>
<text top="878" left="487" width="304" height="19" font="4">Occlusal caries (oc) on upper first left decidual </text>
<text top="897" left="457" width="329" height="19" font="4">molar (64) and on lower first molar (84) can be ob-</text>
<text top="915" left="457" width="44" height="19" font="4">served.</text>
<text top="934" left="487" width="305" height="19" font="4">A slight eruptive delay of the teeth on both </text>
<text top="953" left="457" width="334" height="19" font="4">dental arches can be noticed. Dental age is relevant </text>
<text top="972" left="457" width="334" height="19" font="4">for a 4 and half year-old child. Retromolar space is </text>
<text top="991" left="457" width="143" height="19" font="4">not enough developed.</text>
<text top="1010" left="487" width="300" height="19" font="4">The lips level is inverted with a thick and re-</text>
<text top="1028" left="457" width="101" height="19" font="4">versed lower lip.</text>
<text top="1068" left="457" width="12" height="18" font="1">R</text>
<text top="1072" left="469" width="44" height="13" font="0">ESULTS</text>
<text top="1068" left="514" width="5" height="18" font="1"> </text>
<text top="1072" left="519" width="25" height="13" font="0">AND</text>
<text top="1068" left="544" width="5" height="18" font="1"> </text>
<text top="1072" left="550" width="74" height="13" font="0">DISCUSSION</text>
<text top="1104" left="487" width="300" height="19" font="4">The disruptions that have occurred had result-</text>
<text top="1122" left="457" width="334" height="19" font="4">ed in physiognomic dysfunctions, for which patients </text>
<text top="1141" left="457" width="333" height="19" font="4">have requested dental care. The main problem is the </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="11" size="11" family="Times" color="#ffffff"/>
<image top="126" left="106" width="376" height="274" src="/export/freefileconvert/13160_26d5613051bc52460863b7f656d61c1ab70c93db28550ed3e9f3f2c9825989d8-5_1.png"/>
<image top="126" left="492" width="295" height="274" src="/export/freefileconvert/13160_26d5613051bc52460863b7f656d61c1ab70c93db28550ed3e9f3f2c9825989d8-5_2.png"/>
<text top="91" left="552" width="235" height="14" font="9">Archives of the Balkan Medical Union</text>
<text top="1182" left="660" width="42" height="14" font="9">June </text>
<text top="1182" left="693" width="94" height="14" font="9">2019 / 355</text>
<text top="461" left="106" width="333" height="19" font="4">optimization of the masticatory function that can be </text>
<text top="480" left="106" width="333" height="19" font="4">solved at this age, and it will also solve the phonetic </text>
<text top="498" left="106" width="334" height="19" font="4">disorder, followed by the supervision of the growth </text>
<text top="517" left="106" width="330" height="19" font="4">process and intervening with other treatment solu-</text>
<text top="536" left="106" width="335" height="19" font="4">tions after the closure of the process. The clinical </text>
<text top="555" left="106" width="335" height="19" font="4">picture of the patient in the study reproduces the </text>
<text top="574" left="106" width="329" height="19" font="4">data from the specialized literature: structural abnor-</text>
<text top="593" left="106" width="333" height="19" font="4">malities causing severe evolving dental cavities. The </text>
<text top="612" left="106" width="334" height="19" font="4">clinical picture includes bulky volumetric jaw with </text>
<text top="631" left="106" width="330" height="19" font="4">prognatism, protrusion of the upper lip, hypertro-</text>
<text top="650" left="106" width="317" height="19" font="4">phied gums, small teeth with implantation vices</text>
<text top="650" left="423" width="9" height="11" font="7">10</text>
<text top="650" left="432" width="8" height="19" font="4">. </text>
<text top="669" left="106" width="329" height="19" font="4">Regular check –ups at the dental office and monitor-</text>
<text top="688" left="106" width="334" height="19" font="4">ing the case are very important but beneficial at the </text>
<text top="707" left="106" width="334" height="19" font="4">same time. Appropriate nutrition is required when </text>
<text top="725" left="106" width="334" height="19" font="4">the patient experiences severe chronic anemia, but </text>
<text top="744" left="106" width="333" height="19" font="4">also to avoid the onset of haemolytic crises caused by </text>
<text top="763" left="106" width="329" height="19" font="4">outbreaks of dental infection. Dentists should con-</text>
<text top="782" left="106" width="334" height="19" font="4">sider, for this category of patients, that any surgical </text>
<text top="801" left="106" width="333" height="19" font="4">procedure will be under antibiotics and immediately </text>
<text top="820" left="106" width="145" height="19" font="4">after blood transfusion</text>
<text top="821" left="251" width="9" height="11" font="7">11</text>
<text top="820" left="259" width="4" height="19" font="4">.</text>
<text top="839" left="136" width="303" height="19" font="4">In the case of minor thalassemia, the patient can </text>
<text top="858" left="106" width="334" height="19" font="4">live a normal life; the signs and symptoms include </text>
<text top="877" left="106" width="330" height="19" font="4">palpitations, fatigue and a family history with this pa-</text>
<text top="896" left="106" width="334" height="19" font="4">thology. Management of minor thalassemia is based </text>
<text top="915" left="106" width="333" height="19" font="4">on iron administration, as the risk of developing iron </text>
<text top="934" left="106" width="317" height="19" font="4">anemia is similar to that of the general population</text>
<text top="934" left="423" width="9" height="11" font="7">12</text>
<text top="934" left="432" width="8" height="19" font="4">. </text>
<text top="953" left="106" width="330" height="19" font="4">In patients with minor thalassemia it is very impor-</text>
<text top="971" left="106" width="333" height="19" font="4">tant to apply complete oral hygiene and adequate and </text>
<text top="990" left="106" width="330" height="19" font="4">personalized treatment of dental cavities, thus elimi-</text>
<text top="1009" left="106" width="333" height="19" font="4">nating the outbreak of dental infection, which may </text>
<text top="1028" left="106" width="329" height="19" font="4">adversely affect the evolution of the disease, accelerat-</text>
<text top="1047" left="106" width="211" height="19" font="4">ing the hemolysis of erythrocytes.</text>
<text top="1066" left="136" width="305" height="19" font="4">In severe forms, disease management is based </text>
<text top="1085" left="106" width="335" height="19" font="4">on transfusions and on the administration of iron </text>
<text top="1104" left="106" width="333" height="19" font="4">chelators. New research that leads to an in-depth </text>
<text top="1123" left="106" width="334" height="19" font="4">knowledge of the molecular and pathogenic factors </text>
<text top="1142" left="106" width="333" height="19" font="4">governing the pathogenic mechanisms of the disease </text>
<text top="461" left="457" width="329" height="19" font="4">has suggested ways to develop new therapeutic ap-</text>
<text top="480" left="457" width="329" height="19" font="4">proaches addressing ineffective erythropoiesis, im-</text>
<text top="498" left="457" width="333" height="19" font="4">balances  in  iron  metabolism  and  specific  clinical </text>
<text top="517" left="457" width="91" height="19" font="4">complications </text>
<text top="518" left="548" width="20" height="11" font="7">13,14</text>
<text top="517" left="568" width="4" height="19" font="4">.</text>
<text top="557" left="457" width="12" height="18" font="1">C</text>
<text top="561" left="469" width="77" height="13" font="0">ONCLUSIONS</text>
<text top="593" left="487" width="300" height="19" font="4">This diverse, multiple and potentially aggravat-</text>
<text top="612" left="457" width="333" height="19" font="4">ing pathology, can be improved and the patient’s life </text>
<text top="631" left="457" width="330" height="19" font="4">can also be improved through multi-disciplinary ther-</text>
<text top="650" left="457" width="333" height="19" font="4">apeutic strategies (pediatrician, hematologist, dentist, </text>
<text top="669" left="457" width="84" height="19" font="4">psychologist).</text>
<text top="687" left="487" width="304" height="19" font="4">The dentist can provide prophylactic education </text>
<text top="706" left="457" width="329" height="19" font="4">for the children and their parents in order to en-</text>
<text top="725" left="457" width="333" height="19" font="4">hance a good dental hygiene, dental follow-ups in the </text>
<text top="744" left="457" width="334" height="19" font="4">first signs of cavities or infection. The dentist can </text>
<text top="763" left="457" width="334" height="19" font="4">perform an early diagnosis and treat the diagnosed </text>
<text top="782" left="457" width="65" height="19" font="4">pathology.</text>
<text top="801" left="487" width="304" height="19" font="4">Last, but not least, parents need to be part of </text>
<text top="820" left="457" width="330" height="19" font="4">this team, which, through awareness of this pathol-</text>
<text top="839" left="457" width="334" height="19" font="4">ogy and collaboration with the dentist, reduces the </text>
<text top="858" left="457" width="282" height="19" font="4">suffering and complications that may appear.</text>
<text top="919" left="457" width="267" height="15" font="3">Compliance with Ethics Requirements:</text>
<text top="933" left="487" width="304" height="19" font="8"><i>„The authors declare no conflict of interest regarding </i></text>
<text top="952" left="457" width="65" height="19" font="8"><i>this article“</i></text>
<text top="971" left="487" width="300" height="19" font="8"><i>„The authors declare that all the procedures and ex-</i></text>
<text top="990" left="457" width="334" height="19" font="8"><i>periments of this study respect the ethical standards in the </i></text>
<text top="1009" left="457" width="334" height="19" font="8"><i>Helsinki Declaration of 1975, as revised in 2008(5), as </i></text>
<text top="1028" left="457" width="334" height="19" font="8"><i>well as the national law. Informed consent was obtained </i></text>
<text top="1047" left="457" width="243" height="19" font="8"><i>from all the patients included in the study“</i></text>
<text top="1066" left="487" width="153" height="19" font="8"><i>„No funding for this study“</i></text>
<text top="1085" left="487" width="303" height="19" font="8"><i>„All authors contributed equally to the study and take </i></text>
<text top="1104" left="457" width="333" height="19" font="8"><i>responsibility for the integrity of the data and the accuracy </i></text>
<text top="1123" left="457" width="119" height="19" font="8"><i>of the data analysis.“</i></text>
<text top="403" left="184" width="524" height="15" font="10"><b>Figure 2. </b>Thalassemic male, 5 years old, patient’s upper arcade (a) and lower arcade (b) view.</text>
<text top="380" left="116" width="11" height="15" font="11"><b>a)</b></text>
<text top="380" left="502" width="12" height="15" font="11"><b>b)</b></text>
</page>
<page number="6" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="12" size="11" family="Times" color="#231f20"/>
<text top="91" left="106" width="415" height="14" font="9">Oro-dental clinical aspects in children with thalassemia – KOZMA et al</text>
<text top="1182" left="106" width="143" height="14" font="9">356  /  vol. 54, no. 2</text>
<text top="126" left="106" width="12" height="18" font="1">R</text>
<text top="130" left="118" width="71" height="13" font="0">EFERENCES</text>
<text top="161" left="106" width="335" height="15" font="9">1.<b>  </b>Mut Popescu D. Hematologie clinica. Ed. Medicala </text>
<text top="177" left="128" width="133" height="15" font="9">Bucuresti, 1999, p. 86-89.</text>
<text top="192" left="106" width="330" height="15" font="9">2.<b>  </b>Zohreh R. Genetic epidemiology, hematological and clini-</text>
<text top="208" left="128" width="313" height="15" font="9">cal features of hemoglobinopathies in Iran. <i>Biomed Res </i></text>
<text top="224" left="128" width="128" height="15" font="12"><i>Int. </i>2013; 2013: 803487. </text>
<text top="240" left="106" width="330" height="15" font="9">3.<b>  </b>Weatherall DJ. Current trends in the diagnosis and man-</text>
<text top="255" left="128" width="311" height="15" font="9">agement of haemoglobinopathies. <i>Scand J Clin Lab Invest.</i> </text>
<text top="271" left="128" width="75" height="15" font="9">2007;67(1):1-2.</text>
<text top="287" left="106" width="333" height="15" font="9">4.<b>  </b>Cherry  L,  Calo  C,  Talmaci  R,  Perrin  P,  Gavrila  L. </text>
<text top="301" left="128" width="308" height="17" font="9">-Thalassemia haplotypes in Romania in the context of ge-</text>
<text top="318" left="128" width="312" height="15" font="9">netic mixing in the Mediterranean area. <i>Hemoglobin.</i> 2016; </text>
<text top="334" left="128" width="62" height="15" font="9">40(2):85-96.</text>
<text top="350" left="106" width="333" height="15" font="9">5.<b>  </b>Birgens H, Ljung R. The thalassaemia syndromes. <i>Scand J </i></text>
<text top="366" left="128" width="167" height="15" font="12"><i>Clin Lab Invest</i>. 2007;67(1):11-25.</text>
<text top="381" left="106" width="333" height="15" font="9">6.<b>  </b>Covic  M,  Stefanescu  D,  Sadovici  I.  Genetica  medicala. </text>
<text top="397" left="128" width="211" height="15" font="9">Editia a II-a. Editura Polirom, Iasi, 2011.</text>
<text top="126" left="457" width="335" height="15" font="9">7.<b>  </b>Geormaneanu M. Patologie indusa prenatal. Editura </text>
<text top="142" left="478" width="139" height="15" font="9">Medicala, Bucuresti, 1978.</text>
<text top="158" left="457" width="333" height="15" font="9">8.<b>  </b>Puiu M, Skrypnyk C. Mic ghid de diagnostic în bolile rare. </text>
<text top="173" left="478" width="204" height="15" font="9">Editura Victor Babes, Timisoara, 2009.</text>
<text top="189" left="457" width="329" height="15" font="9">9.<b>  </b>Angelucci E, Pilo F, Coates TD. Transplantation in thalas-</text>
<text top="205" left="478" width="312" height="15" font="9">semia: revisiting the Pesaro risk factors 25 years later. <i>Am J </i></text>
<text top="221" left="478" width="147" height="15" font="12"><i>Hematol. </i>2017;92(5):411-413.</text>
<text top="236" left="457" width="332" height="15" font="9">10.<b>  </b>Al-Wahadni AM, Taani DQ, Al-Omari MO. Dental diseases </text>
<text top="252" left="478" width="312" height="15" font="9">in subjects with beta-thalassemia major. <i>Community Dent </i></text>
<text top="268" left="478" width="180" height="15" font="12"><i>Oral Epidemiol</i>. 2002; 30(6):418-22.</text>
<text top="284" left="457" width="330" height="15" font="9">11.<b>  </b>Helmi N, Bashir M, Shireen A, Ahmed IM. Thalassemia re-</text>
<text top="299" left="478" width="313" height="15" font="9">view: features, dental considerations and management. </text>
<text top="315" left="478" width="204" height="15" font="12"><i>Electron Physician.</i> 2017;9(3):4003-4008.</text>
<text top="331" left="457" width="330" height="15" font="9">12.<b>  </b>Choudhry VP. Thalassemia minor and major: current man-</text>
<text top="347" left="478" width="232" height="15" font="9">agement. <i>Indian J Pediatr</i>. 2017;84(8):607-611.</text>
<text top="362" left="457" width="334" height="15" font="9">13. Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. </text>
<text top="378" left="478" width="186" height="15" font="12"><i>Lancet. </i> 2018;13;391(10116):155-167.</text>
<text top="394" left="457" width="329" height="15" font="9">14.<b>  </b>Cappellini MD, Motta I. New therapeutic targets in trans-</text>
<text top="410" left="478" width="311" height="15" font="9">fusion-dependent and independent thalassemia. <i>Hematology </i></text>
<text top="425" left="478" width="272" height="15" font="12"><i>Am Soc Hematol Educ Program</i>. 2017; 2017(1):278-283.</text>
</page>
</pdf2xml>
